Conference: DMR-NIBIB Planning Workshop: Leveraging data-driven design and synthetic biology to enable next-generation active biomaterials

会议:DMR-NIBIB 规划研讨会:利用数据驱动设计和合成生物学实现下一代活性生物材料

基本信息

  • 批准号:
    2335176
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-15 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Non-technical Abstract:This award will support a planning workshop at the University of Oregon entitled “Leveraging data-driven design and synthetic biology to enable next-generation active biomaterials” as part of a new collaboration between the National Science Foundation’s Division of Materials Research (DMR) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Biomaterials have evolved from ‘off the shelf’ materials to materials that actively interact with biological systems such as the human body. This “next generation” of biomaterials have tunable properties for numerous biological applications, including tissue engineering, integrative biology, and drug delivery. These scientific contributions have shown great promise in advancing biology and human health; however, a major gap exists in converting these exciting advances in materials science into feasible approaches tailored toward pressing biomedical problems. This workshop will be a forum to highlight and explore the recent developments in the field and facilitate the development of a multidisciplinary plan to bridge the gap to clinical translation. This workshop will focus on 4 topics integral to developing and translating next-generation biomaterials: data-driven methods for biomaterials design, synthetic biology-enabled biomaterials, smart/responsive biomaterials, and biofabrication and biointerfaces. The objectives of the workshop are to: I. Showcase recent advances in the next generation biomaterials; II. Facilitate a dialogue between polymer scientists, chemists, bioengineers, and biologists to further the design and application of biomaterials and to bridge the gap to clinical translation; and III. Broaden the (1) scope of biomaterials research to match the diversity of patient populations (ethnicity, gender, etc.) and (2) participants, especially from historically marginalized groups, to drive creative and unique approaches to biomaterials research.Technical Abstract:This award will support a planning workshop at the University of Oregon entitled “Leveraging data-driven design and synthetic biology to enable next-generation active biomaterials” as part of a new collaboration between the National Science Foundation’s Division of Materials Research (DMR) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Biomaterials have evolved from implanted ‘off the shelf’ materials to rationally designed materials that interact with and instruct biological systems to achieve desired biological outcomes. This “next generation” of biomaterials are currently being developed to meet the growing demand for materials with tailored and tunable properties for numerous biological applications, including tissue engineering, integrative biology, and drug delivery. These scientific contributions have shown great promise in advancing numerous biomaterials-based applications. However, a major gap exists in converting these exciting advances in materials science to feasible approaches tailored toward pressing biomedical problems, including achieving robust tissue regeneration after injury/disease, tuning localized and on-demand drug delivery, and enabling real-time biosensing. This workshop will be a forum to highlight and explore the recent developments in the field and facilitate the development of a multidisciplinary plan to bridge the gap to clinical translation. This workshop will focus on 4 integrated science drivers integral to developing and translating next-generation biomaterials: data-driven methods for biomaterials design, synthetic biology-enabled biomaterials, smart/responsive biomaterials, and biofabrication and biointerfaces. The objectives of the workshop are to: I. Showcase recent advances in the various science drivers’ topics of next-generation biomaterials; II. Facilitate a dialogue between polymer scientists, chemists, bioengineers, and biologists to further the design and application of biomaterials and develop a multidisciplinary plan to bridge the gap to translation; and III. Broaden the (1) scope of applications of translational biomaterials to match the diversity of patient populations (ethnicity, gender, etc.) and (2) participants, especially from historically marginalized groups, to drive creative and unique approaches. Highlighting the advances of interdisciplinary investigators from diverse backgrounds is vital to providing nucleation of these forward-looking research avenues.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
非技术摘要:该奖项将支持俄勒冈州大学的一个规划研讨会,题为“利用数据驱动的设计和合成生物学实现下一代活性生物材料”,作为国家科学基金会材料研究部(DMR)和国家生物医学成像和生物工程研究所(NIBIB)之间新合作的一部分。生物材料已经从“现成的”材料发展到与人体等生物系统积极相互作用的材料。这种“下一代”生物材料具有可调的特性,可用于许多生物学应用,包括组织工程、整合生物学和药物递送。这些科学贡献在推进生物学和人类健康方面显示出巨大的潜力;然而,在将材料科学中这些令人兴奋的进展转化为针对紧迫的生物医学问题的可行方法方面存在重大差距。本次研讨会将是一个论坛,突出和探讨该领域的最新发展,并促进多学科计划的发展,以弥合临床翻译的差距。该研讨会将重点关注开发和翻译下一代生物材料不可或缺的4个主题:生物材料设计的数据驱动方法,合成生物学启用的生物材料,智能/响应生物材料以及生物织物和生物界面。讲习班的目标是:展示下一代生物材料的最新进展;二。促进聚合物科学家,化学家,生物工程师和生物学家之间的对话,以进一步设计和应用生物材料,并弥合临床翻译的差距;和III.扩大生物材料研究的范围,以匹配患者人群的多样性(种族、性别等)技术摘要:该奖项将支持俄勒冈州大学举办的一个题为“利用数据驱动设计和合成生物学实现下一代活性生物材料”的规划研讨会,该研讨会是美国国家科学基金会材料研究部(DMR)和美国国家生物医学成像和生物工程研究所(NIBIB)之间新合作的一部分。生物材料已经从植入的“现成”材料发展到合理设计的材料,这些材料与生物系统相互作用并指导生物系统实现预期的生物学结果。目前正在开发这种“下一代”生物材料,以满足对具有定制和可调特性的材料日益增长的需求,用于许多生物应用,包括组织工程,整合生物学和药物递送。这些科学贡献在推进许多基于生物材料的应用方面显示出巨大的前景。然而,在将材料科学中这些令人兴奋的进展转化为针对紧迫的生物医学问题定制的可行方法方面存在重大差距,包括在损伤/疾病后实现强大的组织再生,调整局部和按需药物递送,以及实现实时生物传感。本次研讨会将是一个论坛,突出和探讨该领域的最新发展,并促进多学科计划的发展,以弥合临床翻译的差距。该研讨会将重点关注开发和转化下一代生物材料所不可或缺的4个综合科学驱动因素:生物材料设计的数据驱动方法,合成生物学启用的生物材料,智能/响应生物材料以及生物织物和生物界面。讲习班的目标是:展示下一代生物材料的各种科学驱动主题的最新进展;促进聚合物科学家,化学家,生物工程师和生物学家之间的对话,以进一步设计和应用生物材料,并制定多学科计划,以弥合翻译的差距;和III.扩大(1)转化生物材料的应用范围,以匹配患者人群的多样性(种族、性别等)以及(2)参与者,特别是来自历史上被边缘化的群体,以推动创造性和独特的方法。突出来自不同背景的跨学科研究人员的进步对于这些前瞻性研究途径的形成至关重要。该奖项反映了NSF的法定使命,并被认为值得通过使用基金会的知识价值和更广泛的影响审查标准进行评估来支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Danielle Benoit其他文献

Effect of Zinc on improving silver diamine fluoride-derived tooth discoloration in vitro
  • DOI:
    10.1186/s12903-024-05197-3
  • 发表时间:
    2024-11-19
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Abdullah Almulhim;Astrid C. Valdivia-Tapia;Guilherme Roncari Rocha;Yan Wu;Xinyue Mao;Nora Alomeir;Danielle Benoit;Anderson T. Hara;Tong Tong Wu;Jin Xiao;Yihong Li
  • 通讯作者:
    Yihong Li

Danielle Benoit的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Danielle Benoit', 18)}}的其他基金

Next-generation PEGylation: antifouling and immunoevasive semi-randomized zwitterionic peptides
下一代聚乙二醇化:防污和免疫逃避的半随机两性离子肽
  • 批准号:
    2325340
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
Collaborative Research: Modular, vascularized microphysiological systems to study the outer blood retinal barrier
合作研究:模块化、血管化的微生理系统研究外血视网膜屏障
  • 批准号:
    2225438
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
Collaborative Research: Modular, vascularized microphysiological systems to study the outer blood retinal barrier
合作研究:模块化、血管化的微生理系统研究外血视网膜屏障
  • 批准号:
    2308628
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
Next-generation PEGylation: antifouling and immunoevasive semi-randomized zwitterionic peptides
下一代聚乙二醇化:防污和免疫逃避的半随机两性离子肽
  • 批准号:
    2103553
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
CAREER: Polymer therapeutics for bone regeneration: next-generation osteoporosis treatments
职业:用于骨再生的聚合物疗法:下一代骨质疏松症治疗
  • 批准号:
    1450987
  • 财政年份:
    2015
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
Synthetic Tools for Understanding Biological Phenomena
理解生物现象的综合工具
  • 批准号:
    1358090
  • 财政年份:
    2013
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
Developing materials strategies to control siRNA spatial and temporal delivery to engineer multicomponent tissues
开发材料策略来控制 siRNA 的空间和时间传递,以设计多组分组织
  • 批准号:
    1206219
  • 财政年份:
    2012
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant

相似国自然基金

Dlk1-Meg3印记控制区IG-DMR甲基化重编程介导父体咖啡因暴露所致子代骨质疏松症易感
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
泛素连接酶DDEL1/2/3介导水杨酸羟化酶DMR6降解调控植物免疫的分子机制
  • 批准号:
    32300255
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PpbHLH14-DMR6-like响应MeJA诱导增强梨炭疽病抗性的分子机制
  • 批准号:
    32302484
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
circRNA-DMR介导m6A去甲基化酶ALKBH5低表达并促进糖尿病视网膜小胶质细胞M1型极化的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
Dlk1-Dio3印记区域内母本甲基化差异甲基化区Meg8-DMR的功能研究
  • 批准号:
    31771601
  • 批准年份:
    2017
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
猪RTL1基因DMR甲基化状态对其印记状态及表达水平的调控
  • 批准号:
    31201791
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
雌激素信号介导Igf2-H19 DMR低甲基化在p,p'-DDE致雄性生殖毒性中的作用
  • 批准号:
    81102161
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

FrostBite-DMR - A new Drug-Free Approach for Treating Type 2 Diabetes Supplemental Request
FrostBite-DMR - 一种治疗 2 型糖尿病的新无药方法补充请求
  • 批准号:
    10748325
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
FrostBite-DMR - A New Drug-Free Approach for Treating Type 2 Diabetes
FrostBite-DMR——一种治疗 2 型糖尿病的无药物新方法
  • 批准号:
    10596881
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
NSF/DMR-BSF: Artificial Semiconductor Nanocrystal Molecules for Charge Carrier Separation
NSF/DMR-BSF:用于电荷载流子分离的人造半导体纳米晶体分子
  • 批准号:
    2026741
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
慢性骨髄性白血病におけるDMR達成率向上の治療戦略の開発
制定提高慢性粒细胞白血病 DMR 达成率的治疗策略
  • 批准号:
    21K08362
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
RUI: DMR: Bespoke low-dimensional magnets: from chiral chains to skyrmion candidates
RUI:DMR:定制低维磁体:从手性链到斯格明子候选者
  • 批准号:
    2104167
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant
NSF/DMR-BSF: Theory of Quantum Materials
NSF/DMR-BSF:量子材料理论
  • 批准号:
    2000987
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
NSF/DMR-BSF: Synergistic biopolymer co-assembly regulating the emergence of translation and replication in synthetic networks
NSF/DMR-BSF:协同生物聚合物共组装调节合成网络中翻译和复制的出现
  • 批准号:
    2004846
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant
RUI: NSF/DMR-BSF: Nonequilibrium Quantum Matter: Timescales and Self-Averaging
RUI:NSF/DMR-BSF:非平衡量子物质:时间尺度和自平均
  • 批准号:
    1936006
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant
慢性骨髄性白血病におけるDMR達成率向上の治療戦略の開発
制定提高慢性粒细胞白血病 DMR 达成率的治疗策略
  • 批准号:
    20K08703
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NSF/DMR-BSF: Electronic Correlations and Disorder in Berry materials
NSF/DMR-BSF:浆果材料中的电子相关性和无序性
  • 批准号:
    2002795
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了